VYGR

VYGR EBITDA Growth

-0.73%TTM

Period ending:

VYGR TTM EBITDA YoY %%
VYGR TTM EBITDA YoY %1160.15%-3631.51%
2015-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

VYGR ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 43 observations from Dec 31, 2015 to Jun 30, 2026.

Voyager Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-0.726%
-41.6356%
-93.801%
-483.3187%
-790.1997%
-3,167.8004%
-143.0266%
-44.344%
-85.2123%
-97.5127%
444.6009%
696.4446%
292.3974%
263.9285%
42.0142%
90.3999%
-646.7229%
-308.4227%
-322.2012%
-344.0696%
115.5422%
172.8%
166.4558%
173.2346%
-3.9844%
56.4986%
46.7663%
28.4844%
26.2299%
-30.5762%
-25.512%
-8.4959%
-35.6888%
-45.7694%
-72.7105%
-110.1126%
-112.3872%
-126.8485%
-107.0113%
-104.5219%
-69.3156%
-40.1937%
-38.5743%

Compare ebitda growth

All VYGR financial metrics · VYGR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.